According to Regulus Therapeutics's latest financial reports the company's current earnings (TTM) are -โน2.94 B. In 2023 the company made an earning of -โน2.47 B a decrease over its 2022 earnings that were of -โน2.32 B.The earnings displayed on this page is the company's Pretax Income.